Treatment outcome and germline predictive factors of ropeginterferon alpha‐2b in myeloproliferative neoplasm patients

Documenti analoghi

• CiMRAG: CiM-Aware Domain-Adaptive and Noise-Resilient Retrieval-Augmented Generation for Edge-Based LLMs
  di: Chiu, Shih-Hsuan, et al.
  Pubblicazione: (2026)
• Application of machine learning in predicting health perception through military personnel's sense of empowerment
  di: Kun‐Huang Chen, et al.
  Pubblicazione: (2024)
• Unraveling the impact of lysosomal dysfunction on myeloproliferative neoplasm
  di: Hyundong Yoon, et al.
  Pubblicazione: (2024)
• The Path of Efficiency in 18 Asian Economies and Regions: An Analysis of Energy, Industry, and Productivity
  di: Shih‐Yung Chiu, et al.
  Pubblicazione: (2026)
• Are veterans at increased risk of myeloproliferative neoplasms?
  di: Christin B. DeStefano, et al.
  Pubblicazione: (2024)